Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Tilmicosin" patented technology

Tilmicosin is a macrolide antibiotic. It is used in veterinary medicine for the treatment of bovine respiratory disease and enzootic pneumonia caused by Mannheimia (Pasteurella) haemolytica in sheep. In humans, Tilmicosin causes fatal cardiotoxic effects at amounts greater than 1 milliliter when injected, something most commonly seen in veterinary personnel and farmers.

A quantitative weighing device for tilmicosin production

This utility model discloses a quantitative weighing device for tilmicosin production, including a second conveyor line. A drive mechanism is provided on one side of the second conveyor line. The drive mechanism includes a gantry frame with a mounting bracket that slides vertically up and down on its inner side. A telescopic cylinder is horizontally mounted on the mounting bracket, and a support plate is horizontally fixed to the front end of the telescopic cylinder's telescopic rod. Multiple U-shaped placement slots for placing measuring cylinders are provided on the front side of the support plate. The arrangement direction of the U-shaped placement slots is consistent with the conveying direction of the second conveyor line. The openings of the U-shaped placement slots face the front side of the support plate, and multiple weighing sensors are arranged around the top surface of the support plate in a circle around the U-shaped placement slots. This utility model can automatically transport the measuring cylinders after quantitative feeding and can automatically convey the measuring cylinders, improving work efficiency and saving manpower.
Owner:SHANDONG HUACHEN BIOTECHNOLOGY CO LTD

Staphylococcus pseudovulgare AT8 for degrading antibiotics and application thereof

PendingCN122104537ABacteriaWater contaminantsBiotechnologyTrimethoprim
This application provides a *Staphylococcus pseudoci* AT8 strain for degrading antibiotics and its application. The *Staphylococcus pseudoci* is a species of Staphylococcus (…). Staphylococcus The *Staphylococcus pseudocarpa* species, having a 16S rDNA sequence as shown in SEQ ID NO:1, is named... Staphylococcus pseudoxylosus AT8, deposited on November 20, 2025 at the Guangdong Provincial Center for Microbial Culture Collection, accession number: GDMCC No: 67323. This application pertains to *Staphylococcus pseudocarpa*. Staphylococcus pseudoxylosus AT8 can achieve a degradation rate of over 90% for trimethoprim and tilmicosin, and over 78% for enrofloxacin. Furthermore, this application enriches the antibiotic-degrading bacterial strain library, promotes the control of new antibiotic pollutants in livestock and poultry manure and farmland soil, and facilitates the resource-based treatment and safe utilization of solid waste, demonstrating broad application prospects.
Owner:北京市科学技术研究院资源环境研究所(北京市土地修复工程技术研究中心) +1

Automatic nebulization administration system for early warning of cough in pig population in farm

Automatic atomization drug delivery treatment system after cough early warning of farm pig group. The present application relates to the field of automatic breeding technology of animal husbandry. The system comprises a cough monitoring unit, a central control unit, an atomization execution unit and an environmental control linkage unit. The cough monitoring unit carries a data interface to collect and identify pig cough sounds in real time. When the cough frequency reaches the preset threshold, the atomization execution unit is automatically triggered. The atomization execution unit uses high-pressure cutting atomization technology to produce 3-7 μm atomized particles, and carries a cold power system that does not heat throughout the process. The atomization duration is set to 60-120 min. The environmental control linkage unit automatically reduces the ventilation volume to 30%-50% of the normal level during atomization to prolong the retention time of the liquid medicine. The special treatment agent is a water-soluble atomized preparation of tilmicosin. The present application realizes the unmanned automatic linkage of cough monitoring and atomization drug delivery, solves the three defects of large atomized particles, heating damage to drug efficacy during atomization process and the inability of cough monitoring and atomization control to be linked, and significantly improves the drug deposition efficiency through environmental control cooperation.
Owner:王杰文